The Latest: Britain PM defends virus record after criticism
LONDON — Prime Minister Boris Johnson has rejected claims by his former chief aide that he botched Britain’s coronavirus response and is unfit for office.
Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON — Prime Minister Boris Johnson has rejected claims by his former chief aide that he botched Britain’s coronavirus response and is unfit for office.
Health by Sarah Blake, Tiffany Bakker, Zoe Smith, Andrew Koubaridis, Maria Bervanakis 28th May 2021 5:48 AM Premium Content Subscriber only China hit out at the "dark history" of the US intelligence community on Thursday local time, after US President Joe Biden ordered a probe into the Covid-19 origins which threatens to set the course for relations between world's top economies. Washington is reviewing its diplomatic position with China on issues spanning trade, technological supremacy and rights, while it steps up efforts to h...
In this Jan. 15, 2021 photo, a medical worker holds a package for a Sinopharm vaccine at a vaccination facility in Beijing. (AP Photo/Mark Schiefelbein) JAKARTA, Indonesia — Two vaccines made by China’s Sinopharm appear to be safe and effective against Covid-19, according to a study published in a medical journal. The report, published online in the Journal of the American Medical Association, concluded the two vaccines are about 73% and 78% effective, as Sinopharm has previously claimed. Scientists have been waiting for more details about the two vaccines, even though they already are us...
Experts are still researching the rate of effectiveness and transmissibility of some existing strains of concern.
French pharmaceuticals giant Sanofi on Monday (17 May) reported positive results in trials of its belated COVID-19 jab, raising hopes that France can finally make up lost ground after falling behind in the race to develop a vaccine. Sanofi and its British partner GSK said their vaccine candidate “achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from COVID-19” in Phase 2 clinical trials. The results mark a reversal of fortune for Sanofi after disappointing results from initial trials last year left France without its own vac...